Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.
about
Lipids and the endothelium: bidirectional interactionsInsulin resistance, hyperglycemia, and atherosclerosisS100A8 and S100A9 in cardiovascular biology and diseaseMolecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null miceIncrease in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injuryHyperglycemia impairs atherosclerosis regression in mice.Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice.Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteinsLipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetesEffects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient MiceHuman aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- miceDiabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award LectureAnimal models of atherosclerosis.S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory programDiabetic vascular disease and the potential role of macrophage glucose metabolismIn Vivo optical coherence tomography visualization of intraplaque neovascularization at the site of coronary vasospasm: a case reportMacrophage Phenotype and Function in Different Stages of Atherosclerosis.Imaging VEGF receptor expression to identify accelerated atherosclerosis.Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and NntCardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.Diabetes and atherosclerosis: is there a role for hyperglycemia?The Role of Immunogenicity in Cardiovascular Disease.2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.Intraplaque haemorrhages as the trigger of plaque vulnerability.RAGE biology, atherosclerosis and diabetes.Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice.Diabetes-accelerated atherosclerosis and inflammation.Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.Distinct roles of arginases 1 and 2 in diabetic nephropathy.MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men.Linking diabetes and atherosclerosisHyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice
P2860
Q26860086-16284EB8-D7AA-4157-825A-469D2DE74404Q27011696-69DEA0EF-8598-4993-9AC6-2CF5D657EBE5Q27024450-B02A8DB1-C714-4806-B7E2-F4FE3D4A345EQ28070313-095A1164-5295-4AAF-9C69-4C6263A98395Q33586616-8E54067B-6047-4BF7-9158-86C8756CB0C6Q33858160-EE761EB7-A4B6-4C30-A8A2-40F480D1182AQ34459819-75278DC3-6B67-4D61-99B0-A38953012446Q35013804-C81D8DCD-A18E-496F-97D4-033D703FCF64Q35043471-A09677FE-67D1-44B5-8B9F-46213C5F2AF4Q35063189-37A0D735-137A-4E70-B221-A5D97D2E09A3Q35140825-26545C2C-FAE6-4166-A6D7-3A7A2F9A38CEQ35653968-C532101F-21CC-4584-8335-6E0712A60B27Q35753067-748446F3-9D58-46FD-B7DC-2956F43CA339Q35849515-FEF536A2-60EE-4AB4-B088-A1022411EE9DQ35881759-76676418-F8A1-4A7B-80C1-7643D47186F5Q35903298-96563485-AA2B-4D07-A826-F64920DD6370Q35998253-27869804-7E7D-4533-8C59-7D34795373DBQ36199128-8BB8AA0E-0C7E-4F27-A705-EBEDD9286FADQ36203529-408CE9CC-53BC-442F-A806-2B58667128BAQ36602809-DA1AF779-CDEB-4F9E-A470-70425B37F439Q36944432-6B066513-0690-4CCF-8805-B3F8D82193FDQ37097498-5F4EFB01-592E-4C37-8CD8-DA662CC8C5DEQ37172727-9B314152-DF33-4313-A441-B9614BEC8C4CQ37333371-453FB318-9F68-47F9-98D3-1940CECEA110Q37560012-B792884D-CE6D-4450-871F-756A395B47A0Q37666671-122CED7F-1BC6-42E4-9CAF-8E65D14162D7Q37852494-E57FB8CB-9586-4088-9B7C-2E0E2D277B6BQ37860348-C9754456-AC1A-439B-883B-EEFCC99E8727Q39648048-98AFDE7B-BCE7-465F-BE00-9682DCA5A038Q40106543-97FA2FB4-0B0E-46FC-80FD-FFD3E125318EQ42964142-23F46296-B5AA-47E6-B65E-9EAA05C863E7Q50102325-6FBAA3D2-8C68-46A0-A2D6-700D1B7F77B5Q51033386-5299520F-50BE-4462-8F98-26941DE43947Q51572223-3E51F23B-4AB9-4162-8C0B-A32206B7F932Q57182351-760E5DA9-BCDE-4DF5-AB51-D0605EDC0A7DQ57817035-83F4FB33-E495-43E0-9108-3D4448898606
P2860
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Type 1 diabetes promotes disru ...... n LDL receptor-deficient mice.
@en
type
label
Type 1 diabetes promotes disru ...... n LDL receptor-deficient mice.
@en
prefLabel
Type 1 diabetes promotes disru ...... n LDL receptor-deficient mice.
@en
P2093
P2860
P356
P1476
Type 1 diabetes promotes disru ...... in LDL receptor-deficient mice
@en
P2093
Alan Chait
Farah Kramer
Fredrik Johansson
Jay W Heinecke
Karin E Bornfeldt
Kazuhiro Oka
Lawrence Chan
Linda Geng
Rachel D Merrill
Shelley Barnhart
P2860
P304
P356
10.1073/PNAS.0709958105
P407
P577
2008-02-05T00:00:00Z